Key topics to be covered include:
1. Understanding the different ways in which the 340B and Medicaid programs intersect
2. Analyzing CMS’s recently-proposed Medicaid drug rebate rule and how it would impact 340B
3. Pending federal spread pricing legislation that could cut Medicaid managed care reimbursement of 340B drugs
4. State efforts to maximize collection of Medicaid rebates from manufacturers at the expense of covered entities
5. Real-world examples of navigating state-specific challenges to covered entities’ use of 340B drugs for Medicaid patients
Whether you are a seasoned professional or new to the field, this webinar promises to equip you with the knowledge and insights needed to navigate the complexities of 340B and Medicaid, ensuring that you can make informed decisions and optimize your program outcomes.